These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 38012650)
1. Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment. Lv Y; Li M; Weng L; Huang H; Mao Y; Yang DA; Wei Q; Zhao M; Wei Q; Rui K; Han X; Fan W; Cai X; Cao P; Cao M J Exp Clin Cancer Res; 2023 Nov; 42(1):322. PubMed ID: 38012650 [TBL] [Abstract][Full Text] [Related]
2. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Han X; Wei Q; Lv Y; Weng L; Huang H; Wei Q; Li M; Mao Y; Hua D; Cai X; Cao M; Cao P Mol Ther; 2022 Jan; 30(1):327-340. PubMed ID: 34450250 [TBL] [Abstract][Full Text] [Related]
3. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508 [TBL] [Abstract][Full Text] [Related]
6. [Liposome nanoparticles for targeted delivery of parthenolide induce colorectal cancer necroptosis to ameliorate tumor-infiltrating T cell exhaustion in mice]. Yao W; Wang X; Yang Y; You J; Jin J; Zeng P; Han Q; Yao X; Sun X; Zhou J Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1674-1681. PubMed ID: 37933642 [TBL] [Abstract][Full Text] [Related]
7. Targeting sphingosine 1-phosphate receptor 3 inhibits T-cell exhaustion and regulates recruitment of proinflammatory macrophages to improve antitumor efficacy of CAR-T cells against solid tumor. Gao G; Liao W; Shu P; Ma Q; He X; Zhang B; Qin D; Wang Y J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37591632 [TBL] [Abstract][Full Text] [Related]
8. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. Aaboe Jørgensen M; Ugel S; Linder Hübbe M; Carretta M; Perez-Penco M; Weis-Banke SE; Martinenaite E; Kopp K; Chapellier M; Adamo A; De Sanctis F; Frusteri C; Iezzi M; Zocca MB; Hargbøll Madsen D; Wakatsuki Pedersen A; Bronte V; Andersen MH Cancer Immunol Res; 2021 Nov; 9(11):1316-1326. PubMed ID: 34518197 [TBL] [Abstract][Full Text] [Related]
9. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8 Zhang Md J; Zhang Md L; Yang Md Y; Liu Md Q; Ma Md H; Huang Md A; Zhao Md Y; Xia Md Z; Liu Md T; Wu Md G Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1533-1546. PubMed ID: 33238192 [TBL] [Abstract][Full Text] [Related]
10. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569 [TBL] [Abstract][Full Text] [Related]
11. IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model. Lutz V; Hellmund VM; Picard FSR; Raifer H; Ruckenbrod T; Klein M; Bopp T; Savai R; Duewell P; Keber CU; Weigert A; Chung HR; Buchholz M; Menke A; Gress TM; Huber M; Bauer C Cancer Immunol Res; 2023 Apr; 11(4):421-434. PubMed ID: 36758176 [TBL] [Abstract][Full Text] [Related]
12. Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells. Weis-Banke SE; Lisle TL; Perez-Penco M; Schina A; Hübbe ML; Siersbæk M; Holmström MO; Jørgensen MA; Marie Svane I; Met Ö; Ødum N; Madsen DH; Donia M; Grøntved L; Andersen MH J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36316062 [TBL] [Abstract][Full Text] [Related]
13. Blocking LTB Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900 [TBL] [Abstract][Full Text] [Related]
14. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression. Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384 [TBL] [Abstract][Full Text] [Related]
15. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice. Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569 [TBL] [Abstract][Full Text] [Related]
16. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Menjivar RE; Nwosu ZC; Du W; Donahue KL; Hong HS; Espinoza C; Brown K; Velez-Delgado A; Yan W; Lima F; Bischoff A; Kadiyala P; Salas-Escabillas D; Crawford HC; Bednar F; Carpenter E; Zhang Y; Halbrook CJ; Lyssiotis CA; Pasca di Magliano M Elife; 2023 Feb; 12():. PubMed ID: 36727849 [TBL] [Abstract][Full Text] [Related]
17. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8 Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX J Hepatol; 2024 Oct; 81(4):690-703. PubMed ID: 38759889 [TBL] [Abstract][Full Text] [Related]
18. Unveiling YWHAH: A potential therapeutic target for overcoming CD8 Li Q; Yuan Z; Wang Y; Zhai P; Wang J; Zhang C; Shao Z; Xing C Int Immunopharmacol; 2024 Jun; 135():112317. PubMed ID: 38796965 [TBL] [Abstract][Full Text] [Related]
19. Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells. Glöckner HJ; Martinenaite E; Landkildehus Lisle T; Grauslund J; Ahmad S; Met Ö; Thor Straten P; Hald Andersen M Oncoimmunology; 2024; 13(1):2318053. PubMed ID: 38404966 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion. Li F; Wang Y; Chen D; Du Y Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]